Clinical Trials Sponsored by Ovarian Spore

Total 699 results

M.D. Anderson Cancer Center
Ovarian Spore

Withdrawn

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

Uterine Cancer
Royal North Shore Hospital
University of Sydney; Varian Medical Systems

Active, not recruiting

Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking (LIGHTSABR)

Neoplasms | Lung Neoplasms

Australia
Varian Medical Systems

Completed

STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma

Localized Hepatocellular Carcinoma

China
Bavarian Nordic

Recruiting

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

Chikungunya Virus Infection

United States
Bavarian Nordic

Completed

A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

Solid Metastatic Tumor

United States
Bavarian Nordic

Completed

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

Smallpox

United States
Bavarian Nordic

Completed

Special Access Program IMVAMUNE®

Vaccination

United States
Bavarian Nordic

Completed

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect)

Prostate Cancer Metastatic

United States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
Bavarian Nordic

Completed

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer

Breast Cancer

United States
Bavarian Nordic

Withdrawn

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

Respiratory Syncytial Virus Infections
Ovation Fertility

Completed

Comparison of Culture Media for in Vitro Embryo Development (NXGeM)

Infertility

United States
Ovation Fertility

Completed

Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator (TiMMI)

Fertility

United States
Bavarian Nordic

Completed

Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine

Respiratory Syncytial Virus Infections

United States
Bavarian Nordic

Completed

Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects

HIV Infections

United States
Bavarian Nordic

Completed

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

Smallpox

Germany
Bavarian Nordic

Completed

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

Smallpox

Germany
Bavarian Nordic

Completed

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

RSV Infection

United Kingdom
Bavarian Nordic

Active, not recruiting

ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

COVID-19 Disease

Germany
Bavarian Nordic

Completed

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Respiratory Syncytial Virus Infections

United States
Bavarian Nordic

Completed

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Smallpox

United States, Puerto Rico
Bavarian Nordic

Completed

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

Smallpox

United States
Bavarian Nordic

Active, not recruiting

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Chordoma | HER2-positive Breast Cancer | HER2-positive Gastric/Gastroesophageal Junction Cancer

United States
Bavarian Nordic

Completed

ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

COVID-19 Disease

United States, Denmark, Belgium
Bavarian Nordic

Completed

MVA-BN-RSV Vaccine Trial

Respiratory Syncytial Virus Infections

United States, Germany
Bavarian Nordic

Completed

BN Brachyury and Radiation in Chordoma

Chordoma

United States
Bavarian Nordic

Completed

CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Bladder Cancer

United States
Bavarian Nordic

Completed

Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury)

Safety Issues

United States
Bavarian Nordic

Completed

A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

United States
Bavarian Nordic

Completed

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy

Breast Cancer

United States
Bavarian Nordic

Completed

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer (BNIT-PR-001)

Androgen-insensitive Prostate Cancer

United States
Bavarian Nordic

Completed

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

Smallpox

United States
Bavarian Nordic

Completed

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

HIV Infections

Germany
Bavarian Nordic

Completed

Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years

Measles

South Africa
Spire, Inc.

Completed

Spire Medical Health Tag Actigraphy and Sleep Validation in Adults

Healthy Volunteers

United States
Varian, a Siemens Healthineers Company

Recruiting

A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System

Head and Neck Cancer | Thoracic Cancer | Abdominal Cancer | Pelvic Cancer

United States
Columbia University
Varian Medical Systems

Recruiting

Adaptive Radiation in Anal Cancer

Anal Squamous Cell Carcinoma

United States
Varian, a Siemens Healthineers Company

Recruiting

Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix (ARTIA-Cervix)

Cervical Cancer by FIGO Stage 2018

United States
Varian, a Siemens Healthineers Company

Completed

Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01)

Bone Metastasis

United States
Varian, a Siemens Healthineers Company

Completed

Varian ProBeam Proton Therapy System China Clinical Trial (Hefei) (ProBeam)

Tumors

China
Varian, a Siemens Healthineers Company

Completed

CMT-07-08: The PROstate Bed Evaluation Study

Prostate Cancer

United States
University of Washington
Minnesota Ovarian Cancer Alliance

Terminated

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Stage III Ovarian Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA1 Ovarian Cancer AJCC v8 | Stage IIIA2 Ovarian Cancer AJCC v8 | Stage IIIB Ovarian Cancer AJCC v8 | Stage IIIC Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IVA Ovarian Cancer AJCC v8 | Stage IVB Ovarian... and other conditions

United States
Sparian Biosciences, Inc

Recruiting

A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

Pain | Acute Pain

United States
Varian, a Siemens Healthineers Company

Not yet recruiting

Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)

Tumor, Solid
Varian, a Siemens Healthineers Company

Recruiting

Genicular Artery Embolisation for Knee Osteoarthritis II (GENESISII)

Knee Osteoarthritis

United Kingdom
Varian, a Siemens Healthineers Company

Recruiting

HyperArc Registry Study

Brain Metastases | CNS Neoplasm | CNS Disorder, Intracranial

United States, Australia
Stanford University
Varian Medical Systems

Enrolling by invitation

Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer

Quality of Life

United States
Varian, a Siemens Healthineers Company

Completed

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

Tachycardia, Ventricular

United States
Varian, a Siemens Healthineers Company

Completed

Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy (CONFIGURE)

Breast Cancer | Head and Neck Cancer | Lung Cancer | Abdominal Cancer | Pelvic Cancer

Netherlands
Varian, a Siemens Healthineers Company

Active, not recruiting

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer (ARTIA-Lung)

Stage III Non-small Cell Lung Cancer

United States
Varian, a Siemens Healthineers Company

Completed

Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy

Breast Cancer | Lung Cancer | Liver Cancer | Other Cancer

Canada

Clinical Trials Sponsored by Ovarian Spore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations